Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M5BI
|
|||
| Former ID |
DNCL001613
|
|||
| Drug Name |
Ampion
|
|||
| Synonyms |
Ampion (TN)
Click to Show/Hide
|
|||
| Indication | Bronchiectasis [ICD-11: CA24; ICD-10: J47] | Phase 3 | [1] | |
| Company |
Ampio Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H10N2O4
|
|||
| Canonical SMILES |
CC1C(=O)NC(C(=O)N1)CC(=O)O
|
|||
| InChI |
1S/C7H10N2O4/c1-3-6(12)9-4(2-5(10)11)7(13)8-3/h3-4H,2H2,1H3,(H,8,13)(H,9,12)(H,10,11)/t3-,4-/m0/s1
|
|||
| InChIKey |
RVLCUCVJZVRNDC-IMJSIDKUSA-N
|
|||
| CAS Number |
CAS 110954-19-3
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01839331) A Efficacy and Safety Study of Two Doses of Intra-Articular Injection of Ampion in Adults With Pain Due to Osteoarthritis of the Knee. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.